Your Team of Experts

 

Together, we have more than 100 years of leadership experience in the IP, Medical, Legal and Innovation fields.

 

Andy Choi - Co-Found & CEO

Mr. Choi has over 20 years of experience in product development and commercialization with expertise in the medical device industry.  He has held executive positions ranging from engineering to marketing and sales in start-up settings to Fortune 500 companies.

Dr. Jeffrey Roh - Co-Founder & CMO

Dr. Roh has over fifteen years of experience as an inventor, angel investor, and serial entrepreneur and holds multiple patents through the USPTO. He currently serves as a consultant on Stryker corporation’s Surgical Design and Innovation team as well as serving as chair and board member to several spine and medical hospitals and organizations.

Simon Robinson - Co-Founder & CIPO

Mr. Robinson has extensive IP transactional and monetization experience. Over the past 10 years he has completed over 150 IP transactions ranging from small single asset sales to multi-faceted, complex transactions with hundreds of assets and a transaction value of eight figures. His clients have included individual inventors, universities, privately-held companies and Fortune 500 corporations.

Josh Chung - Co-Founder & CFO

Mr. Chung is a certified public accountant with almost 20 years of experience in providing management advisory and attestation services. His professional experience ranges from initial public offerings, mergers, and acquisitions, financial due diligence, SEC registration statements and Sarbanes-Oxley 404 among many others.

Mark Han - Co-Founder & CLO

Mr. Han specializes in intellectual property law with an emphasis on strategic portfolio development, investment due diligence, and commercialization of IP. Mr. Han previously served as Senior IP Counsel at Intellectual Ventures where his team was responsible for managing all aspects of prosecution and asset maintenance for one of the world’s largest patent portfolios, with more than 30,000 assets and over $6 billion in investor capital.